Pharmaceutical firms pile up cash reserves

Korean drug companies piled up cash reserves in the first half of this year, as they refrained from investing amid the market downturn stemming from the impact of the drug price cuts in April.

According to a report released by Yakup.com, a pharmaceutical information provider, Cashable assets of 53 listed companies totaled 1.13 trillion won as of the end of June this year.

The report said ...